Argus raises Cardinal Health price target following strong earnings
Alpha Vantage · Investing.com Canada · · AI-summarised by FinFlash
Argus raised its price target on Cardinal Health to $309 from $264 while maintaining a Buy rating after robust first-quarter results. The company beat revenue and adjusted profit expectations, lifting its fiscal 2027 earnings guidance alongside solid segment growth. For investors, the upward revision highlights operational momentum and improving cash generation.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.